Our Therapeutic Pipeline

At conveyxo, we’re dedicated to pioneering new treatments that benefit patients.

We develop RNA-enhanced therapeutics exosomes to reverse the root cause of inflammatory conditions and degenerative diseases.
Our pipeline represents our commitment to transforming patient care, with programs in discovery, through pre-clinical development, to clinic in early 2027.

Our Mission: Tackling Degenerative Diseases Through Cellular Innovation

At ConvEyXO, our mission is to slow the progression of degenerative diseases by addressing their biological roots.
We focus on extending healthspan — the years of life lived in good health — through the development of miRNA-enhanced exosome therapeutics.
By targeting inflammation and cellular aging, our technology platform helps restore balance and regenerative capacity across multiple disease pathways.

Conveyxo RNA-enhanced exosomes pipeline

Current treatments for degenerative and inflammatory diseases only manage symptoms, not their root cause, leaving a massive unmet need.

Conveyxo develops RNA-enhanced exosomes designed to reduce inflammation, restore cellular balance, and address degenerative diseases at their biological roots.

Our lead programs focus on osteoarthritis (EXOSTEO01) and dermatological conditions (DERMEXO01), with a path toward first-in-human studies.

Our Mission: Tackling Degenerative Diseases Through Cellular Innovation

At ConvEyXO, our mission is to slow the progression of degenerative diseases by addressing their biological roots.
We focus on extending healthspan — the years of life lived in good health — through the development of miRNA-enhanced exosome therapeutics.
By targeting inflammation and cellular aging, our technology platform helps restore balance and regenerative capacity across multiple disease pathways.

Expanding Indications Through Strategic Partnerships

In collaboration with external research and industry partners, we extend our exosome platform into additional therapeutic areas. These joint programs broaden our impact and accelerate development across inflammation-driven diseases.

Our Vision: A Future Where Degenerative Diseases Can Be Prevented, Not Managed.

As populations age, chronic inflammatory and degenerative conditions are becoming one of humanity’s greatest challenges.
ConvEyXO envisions a future where regenerative medicine restores vitality at the cellular level, reducing healthcare burdens and improving quality of life for millions.